Hedgehog inhibitors from Withania somnifera

Bioorg Med Chem Lett. 2015 Sep 1;25(17):3541-4. doi: 10.1016/j.bmcl.2015.06.081. Epub 2015 Jun 30.

Abstract

The hedgehog (Hh) signaling pathway performs an important role in embryonic development and in cellular proliferation and differentiation. However, aberrant activation of the Hh signaling pathway is associated with tumorigenesis. Hh signal inhibition was evaluated using a cell-based assay system that targets GLI1-mediated transcription. Activity-guided isolation of the Withania somnifera MeOH extract led to the isolation of six compounds: withaferin A (1) and its derivatives (2-6). Compounds 1 and 2 showed strong inhibition of Hh/GLI1-mediated transcriptional activity with IC50 values of 0.5 and 0.6 μM, respectively. Compounds 1, 2, 3, and 6 were cytotoxic toward human pancreatic (PANC-1), prostate (DU145) and breast (MCF7) cancer cells. Furthermore, 1 also inhibited GLI1-DNA complex formation in EMSA.

Keywords: Hedgehog signaling pathway; Inhibitor; Natural product; Withania somnifera.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents, Phytogenic / chemistry*
  • Antineoplastic Agents, Phytogenic / isolation & purification
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Cell Line, Tumor
  • Female
  • Hedgehog Proteins / antagonists & inhibitors*
  • Hedgehog Proteins / metabolism
  • Humans
  • Male
  • Neoplasms / drug therapy
  • Neoplasms / metabolism
  • Signal Transduction / drug effects
  • Withania / chemistry*
  • Withanolides / chemistry*
  • Withanolides / isolation & purification
  • Withanolides / pharmacology*

Substances

  • Antineoplastic Agents, Phytogenic
  • Hedgehog Proteins
  • Withanolides
  • withaferin A